-
Mashup Score: 2Cardiovascular Safety Assessment in Cancer Drug Development - 3 year(s) ago
Abstract The development of cardiovascular toxicity attributable to anticancer drugs is a pivotal event that is associated with cardiovascular morbidity as well as with worse cancer‐specific and ov…
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Scientific Sessions 2021 - 3 year(s) ago
Meet with us for compelling content and renewed connections at AHA Scientific Sessions 2021. In-person Event in Boston, Massachusetts + Virtual Experience, Saturday, November 13-15.
Source: professional.heart.orgCategories: Cardiologists, Latest HeadlinesTweet-
RT @DrTochiOkwuosa: Register #AHA21: https://t.co/vHlRTLsqXb Cardio-Onc programming, hope to "see" you there. #cardiology #oncology #cardio…
-
-
Mashup Score: 3How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy: - 3 year(s) ago
IntroductionImproved monitoring and treatment options have led to dramatic progress in the treatment of cardiovascular disease and cancer. Because of shared risk factors, a substantial number of cancer patients also have pre-existing cardiovascular disease when starting cancer treatment. It is projected that in 2021, there will be almost 1.9 million new cancer diagnoses, and approximately 50% of…
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
After looking at this ?, review our "How To" article w/ easy and safe recs for device mgmt during XRT in #JACCCardioOnc. Collab effort from @ACCinTouch #EPeeps and #cardioonc leadership council and @PennCardiology and @PennCancer @BenedicteLefeb1 https://t.co/vnn3SteuUf https://t.co/YKHrBhn6kp
-
-
Mashup Score: 30How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience - 3 year(s) ago
Central Illustration
Source: JACC: CardioOncologyCategories: Cardiologists, Latest HeadlinesTweet-
RT @JACCJournals: Find out how to perform #pericardiocentesis in cancer patients with #thrombocytopenia ➡️ https://t.co/PEKw0SvVFX #JACCC…
-
-
Mashup Score: 2
-
Mogamulizumab is a CCR4 inhibitor used in the management of T-cell #lymphoma & can rarely cause #myocarditis. The authors discuss the presentation & management in #JACCCaseReports: https://t.co/xfwb42ABxZ #lymsm #CardioOnc #HeartFailure @CardioOnc_MR_CT @jennkwanMDPhD https://t.co/IC7jrfVijM
Read the original tweet here
Source: TwitterCategories: Cardiologists, Latest HeadlinesTweet-
RT @jennkwanMDPhD: Inspired by our case of moga myocarditis https://t.co/NOrftl7LA9, we evaluated adverse CV events post mogamulizumab (imm…
-
-
Mashup Score: 6International Cardio Oncology Society - 3 year(s) ago
GCOS 2021- Virtual will summarize the latest research and best practices in Cardio-Oncology, a multidisciplinary specialty that has gained a growing interest from a large number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists. Hand in hand with leading experts, V-COS aims is to improve our knowledge of the role of…
Source: members.ic-os.orgCategories: Cardiologists, Latest HeadlinesTweet-
Final few hours to register for #gcos21 if you want to learn about #cardioonc and network with international thought leaders, don’t delay and register now! Meeting starts Thursday. @onco_cardiology @ICOSociety @CardioOncRxNet https://t.co/DTzRJccuTJ
-
-
Mashup Score: 2International Cardio Oncology Society - 3 year(s) ago
GCOS 2021- Virtual will summarize the latest research and best practices in Cardio-Oncology, a multidisciplinary specialty that has gained a growing interest from a large number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists. Hand in hand with leading experts, V-COS aims is to improve our knowledge of the role of…
Source: members.ic-os.orgCategories: Cardiologists, Latest HeadlinesTweet-
Back to #GCOS21 tweeting. #Cardioonc community the meeting starts on Thursday 9/30. World experts waiting to engage with you. @ICOSociety @sdent_duke @Ron_Witteles @daniele_andres @dr_manisty @Gulati_Norway @TomasNeilan @dineshpmcc1 https://t.co/DTzRJccuTJ
-
-
Mashup Score: 3International Cardio Oncology Society - 3 year(s) ago
GCOS 2021- Virtual will summarize the latest research and best practices in Cardio-Oncology, a multidisciplinary specialty that has gained a growing interest from a large number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists. Hand in hand with leading experts, V-COS aims is to improve our knowledge of the role of…
Source: members.ic-os.orgCategories: Cardiologists, Latest HeadlinesTweet-
Lets put the Global in #GCOS21 In 2018 we had attendees from 25 countries. Lets get even broader global participation this year. Meeting starts on 9/30. Don't wait. Register here: https://t.co/DTzRJccuTJ @ICOSociety @CCardiacON @PennMDForum @PennCardiology
-
-
Mashup Score: 4International Cardio Oncology Society - 3 year(s) ago
GCOS 2021- Virtual will summarize the latest research and best practices in Cardio-Oncology, a multidisciplinary specialty that has gained a growing interest from a large number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists. Hand in hand with leading experts, V-COS aims is to improve our knowledge of the role of…
Source: members.ic-os.orgCategories: Cardiologists, Latest HeadlinesTweet-
T minus 5 days until the #cardioonc event of the year #gcos21 after you register you’ll hear about one of our social events. Hint: Are you ready? Yes or yes? https://t.co/DTzRJccuTJ @ICOSociety
-
-
Mashup Score: 2International Cardio Oncology Society - 3 year(s) ago
GCOS 2021- Virtual will summarize the latest research and best practices in Cardio-Oncology, a multidisciplinary specialty that has gained a growing interest from a large number of healthcare providers including oncologists, cardiologists, radiologists, nurses, pharmacists, and basic scientists. Hand in hand with leading experts, V-COS aims is to improve our knowledge of the role of…
Source: members.ic-os.orgCategories: Cardiologists, Latest HeadlinesTweet-
#GCOS21 happening in less than a week. #cardioonc event of the year. Here from all the experts across the world and LOTS of opportunity for direct engagement. And there may be a few social surprises yet to be announced. https://t.co/DTzRJbUTv9 @ICOSociety @CardioOncology
-
A+ review by rising #cardioonc 🌟 @OhadOrenMD on cv safety in onc drug dvp. Proud 2 rep @PennCardiology in this collab with @MGHHeartHealth & @BrighamWomens @TomasNeilan @DLBHATTMD @AHA_Research https://t.co/tauI04Ktch